Therapeutic implications of atrial fibrillation mechanisms: can mechanistic insights be used to improve AF management?
about
Assessment of atrial regional and global electromechanical function by tissue velocity echocardiography: a feasibility study on healthy individualsRecent advances in pharmacotherapy of atrial fibrillationSelective molecular potassium channel blockade prevents atrial fibrillationEmerging concepts in the pharmacogenomics of arrhythmias: ion channel trafficking.New insights into the mechanisms and management of atrial fibrillationSurgical treatment of atrial fibrillation: a reviewAtrial electrophysiology and mechanisms of atrial fibrillation.Biological Therapies for Atrial Fibrillation: Ready for Prime Time?Information learned from animal models of atrial fibrillation.Role of TGF-beta on cardiac structural and electrical remodeling.Atrial fibrillation: challenges and opportunities.Application of microRNAs in diagnosis and treatment of cardiovascular disease.Connexin gene transfer preserves conduction velocity and prevents atrial fibrillation.Connexin Remodeling Contributes to Atrial Fibrillation.Increased serum uric acid levels are correlated with decreased left atrial appendage peak flow velocity in patients with atrial fibrillation.2-Aminoethoxydiphenyl borate, a inositol 1,4,5-triphosphate receptor inhibitor, prevents atrial fibrillation.Antiarrhythmic drugs for atrial fibrillation: Do we need better use, better drugs or a randomized trial of ablation as primary therapy?Omega-3 polyunsaturated fatty acids (PUFAs or fish oils) and atrial fibrillation.Association of atrial fibrillation with gene polymorphisms of connexin 40 and angiotensin II receptor type 1 in Chongming adults of Shanghai.Thermal distribution of microwave antenna for atrial fibrillation catheter ablation.Direct action of an angiotensin II receptor blocker on angiotensin II-induced left atrial conduction delay in spontaneously hypertensive rats.A mechanical characterization of the porcine atria at the healthy stage and after ventricular tachypacing.
P2860
Q24795693-1F312F20-7891-4D67-A758-F87EC899A4B2Q33874035-782DBAE2-C803-4045-B0DC-BB0198CBEB08Q33943789-B23E44BF-75DE-42F8-94E9-CA9E5E769016Q34066888-D4499DFD-99C5-47C3-8402-E00F311A2719Q34289414-7F70C7A7-4CBB-483F-AAE1-1B8EDAE34287Q35071043-542487E0-0CD8-4CA3-9998-C622FCBF6FB4Q35127387-89B74040-7792-481C-B3E4-4CFD4F48F070Q36934761-B252E14D-5488-460D-ADF2-0C0E396E9D8AQ37359211-8FAB349F-1EF6-4553-8A34-252C8B1AB0E4Q37428869-BFF792BB-3A2D-4709-839D-602257A13369Q37476763-5EC3D68C-0B31-4E12-981D-58786046F47AQ38264294-504C31AB-C1D2-4738-B4B5-3CCD86364F34Q38435600-B8FDA3B7-4A01-41DF-A94C-C04FAF7F4AD4Q38790389-FD285179-3A6A-4A02-B6A5-AB82179D01A3Q39039941-F856793B-6275-441F-8A5C-48AC5447C3B7Q39703499-D30BBC53-1A01-4739-996A-B789EA379A36Q40025382-275B0A33-D339-47C9-9B65-7E712BFBF90DQ41584950-FB3FEB5C-B83C-41A7-A884-CF1DBF90C235Q43183347-F5D0B9A9-49CE-46D6-A2CD-A6C942958132Q45237685-721675A6-8088-443E-917E-3EB9E9D6A21CQ45933335-396665E6-417C-4029-A05D-6843333A728DQ47934763-0DE0C3B7-E251-4F13-87A5-52440D3916DE
P2860
Therapeutic implications of atrial fibrillation mechanisms: can mechanistic insights be used to improve AF management?
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Therapeutic implications of at ...... used to improve AF management?
@ast
Therapeutic implications of at ...... used to improve AF management?
@en
Therapeutic implications of at ...... used to improve AF management?
@nl
type
label
Therapeutic implications of at ...... used to improve AF management?
@ast
Therapeutic implications of at ...... used to improve AF management?
@en
Therapeutic implications of at ...... used to improve AF management?
@nl
prefLabel
Therapeutic implications of at ...... used to improve AF management?
@ast
Therapeutic implications of at ...... used to improve AF management?
@en
Therapeutic implications of at ...... used to improve AF management?
@nl
P1476
Therapeutic implications of at ...... used to improve AF management?
@en
P2093
Stanley Nattel
P304
P356
10.1016/S0008-6363(01)00562-4
P577
2002-05-01T00:00:00Z